Yoshikazu Asahina

This inventor holds 14 USPTO granted patents and 2 published patent applications, plus 3 CIPO patents and 6 EPO patents. Top assignees: Kyorin Pharmaceutical Co., Ltd., Teijin Pharma Limited. Active years: 1999-2016.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Yoshikazu Asahina. Retrieved from https://idiyas.com/inventor/yoshikazu-asahina

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank

USPTO Granted Patents = 14 (Patent Applications = 2)

% Patents Active = 14.3

CIPO Patents = 3

EPO Patents = 6 (Patent Applications = 2)

Average Co-Inventor Count = 3.6

ph-index = 4

Forward Citations = 28(Granted Patents)

Company Filing History:

14 out of 185

Kyorin Pharmaceutical Co., Ltd.

patents

4 out of 127

Teijin Pharma Limited

patents

where one patent can have more than one assignee

Years Active: 1999-2016

Loading Chart...

14 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 9452977 - Cyclopentylacrylamide derivative (2016-09-27),

2. 8946440 - Cyclopentylacrylamide derivative (2015-02-03),

3. 8222407 - Mutilin derivative having heterocyclic aromatic ring carboxylic acid structure in substituent at 14-position (2012-07-17),

4. 8173649 - Glucokinase activator (2012-05-08),

5. 8106072 - 7- (4-substituted-3-cyclopropylaminomethyl-1-pyrrolidinyl) quinolonecarboxylic acid derivative (2012-01-31),

6. 8053465 - Bicycloester derivative (2011-11-08),

7. 8034819 - Glucokinase activator (2011-10-11),

8. 7915427 - Process for producing aminoacetyl pyrrolidine carbonitrile derivative and intermediate for production thereof (2011-03-29),

9. 7754757 - Bicycloester derivative (2010-07-13),

10. 7560569 - Bicycloamide derivative (2009-07-14),

11. 7514571 - Bicyclo derivative (2009-04-07),

12. 7514451 - 7-(4-Substituted-3-cyclopropylaminomethyl-1 pyrrolidinyl) quinolonecarboxylic acid derivative (2009-04-07),

13. 7153851 - 10-(3-cyclopropylaminomethyl-1-pyrrolidinyl)pyridobenzoxazinecarboxylic acid derivative effective against resistant bacterium (2006-12-26),

14. 5942518 - Water-soluble fluoroethylcamptothecin derivative and process for (1999-08-24),

Title: The Innovations of Yoshikazu Asahina

Introduction

Yoshikazu Asahina is a prominent inventor based in Tochigi, Japan. He has made significant contributions to the field of pharmaceuticals, particularly in the development of compounds with hypoglycemic effects. With a total of 14 patents to his name, Asahina's work has the potential to impact the treatment and prevention of diabetes and obesity.

Latest Patents

One of Asahina's latest patents involves a cyclopentylacrylamide derivative. This compound is designed to have a hypoglycemic effect and is useful for treating or preventing diabetes and obesity. The compound is represented by a specific general formula, where the components can vary, including hydrogen atoms, halogen atoms, and various functional groups. This innovative approach highlights Asahina's commitment to addressing critical health issues through his inventions.

Career Highlights

Throughout his career, Yoshikazu Asahina has worked with notable companies such as Kyorin Pharmaceutical Co., Ltd. and Teijin Pharma Limited. His experience in these organizations has allowed him to refine his skills and contribute to significant advancements in pharmaceutical research and development.

Collaborations

Asahina has collaborated with esteemed colleagues, including Yasumichi Fukuda and Koji Murakami. These partnerships have fostered a collaborative environment that encourages innovation and the sharing of ideas.

Conclusion

Yoshikazu Asahina's contributions to the field of pharmaceuticals through his innovative patents demonstrate his dedication to improving health outcomes. His work continues to pave the way for advancements in the treatment of diabetes and obesity.

Profile summary based on public USPTO records.